It is well known that the NF-κB pathway is crucial for the production of inflammatory cytokines, including IL-6 and TNF-α, both of which are important targets for the treatment of intestinal inflammation (Mao et al., 2018; Waljee et al., 2018). This evidence concerns the gene NFKB1 and inflammatory response.